Philosophy
On the basis of development of original nanoparticle-formulation,
we carry out research and development regarding novel
diagnostics and therapeutics and contribute to health of the nation
and welfare around the world by realizing novel nano-medical
treatment originated in Japan.
History
| Month Year | Overview |
|---|---|
| February 2007 |
Established Sentan Pharm Inc. as a venture company originated from Kyushu University(Capital: ten million yen). Contracted a joint research agreement with Kyusyu University. |
| March 2008 | Started the development of pitavastatin-encapsulated PLGA nanoparticle formulations in collaboration with Kowa Company, Ltd. |
| October 2008 | Contracted a distributorship agreement for nanoparticles with Hosokawa Micron Co. |
| July 2009 | Adopted into the “Fukuoka Prefecture Bio-Ventures Cultivation Project“ in FY 2009. |
| September 2009 | Adopted into the “Okinawa New Industry Research and Development Support Project”. |
| January 2010 | Established Okinawa Laboratory. |
| February 2010 | Received the 10th BIO BUSINESS COMPETITION JAPAN Special Recognition Award. |
| April 2010 | Started manufacturing a nanoparticle formulation under GMP for clinical investigational products. |
| January 2011 | Sumio Mabuchi, Minister of Land, Infrastructure, Transport and TourismJapan's land, infrastructure, and transport minister (at the time), visited our Okinawa Laboratory. |
| April 2011 |
Adopted into the “OKINAWA Industry Support Fund Project” in FY2011. The name of business plan: development of a new product of Ryuteki series, called “Ryukyu no Megumi.” |
| June 2011 | Adopted into the Intellectual Cluster Formation Project (research title: metabolomic study for the technological development of health-longevity improvement through new approaches to the transdermal absorption of the active ingredients), participated in a joint research project of Okinawa Institute of Science and Technology Graduate University |
| February 2012 | Acquired the Specially Controlled Medical Devices Sale License. |
| March 2012 | The capital was increased to thirty million yen. |
| May 2013 |
Shinzou Abe, Japan's prime minister, visited Kyusyu University. Professor Egashira made a presentation “Practical application of a nanoparticle formulation for treatment of severe pulmonary hypertension and its clinical trial.” |
| July 2013 |
Relocated Okinawa Laboratory Concluded a contract of outsourcing agreement for research and development of health foods with Kowa Company, Ltd. Relocated our headquarter office to Shimokawabatamachi, Hakata-ku, Fukuoka, Japan |
| August 2013 |
Adopted into the “OKINAWA Industry Support Fund Project” in FY2013. Adopted into the “Environmental Technology Revolution Project in water and foliage in rural areas toward sixth sector industrialization” in FY2013. |
| December 2013 | Commenced sales of PIT system (PIT catheter, pack for treatment and hand PIT) based on transfer of business. |
| August 2014 | The capital was increased to ninety million yen. |
| September 2014 | Adopted into the “Okinawa Prefecture Life Science Network Formation Project”. |
| March 2015 | The capital was increased to 105.75 million yen. |
| October 2015 | Adopted into the “Collaborative Promotion Project to Create Innovative Monodzukuri (Manufacturing) Industry”. in FY 2015 by the New Energy and Industrial Technology Development Organization (NEDO) |
| December 2015 | The capital was increased to 192.6 million yen. |
| June 2016 |
Adopted into the “Okinawa Scientific and Technological Innovation Formation Project ” in FY 2016. The capital was increased to 194.85 million yen. |
| August 2016 | The capital was increased to 221.4 Million yen. |
| April 2017 | Took over genome analysis and management corporation business from Okinawa Institute of Advanced Sciences. |
